000			01987 a2200565 4500
005			20250514001247.0
264		0	_c20010621
008			200106s 0 0 eng d
022			_a0143-3334
024	7		_a10.1093/carcin/22.6.861 _2doi
040			_aNLM _beng _cNLM
100	1		_aBlagosklonny, M V
245	0	0	_aInhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions. _h[electronic resource]
260			_bCarcinogenesis _cJun 2001
300			_a861-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aArginine _xgenetics
650	0	4	_aBinding Sites
650	0	4	_aBreast Neoplasms _xgenetics
650	0	4	_aCodon _xgenetics
650	0	4	_aConsensus Sequence
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21
650	0	4	_aCyclins _xgenetics
650	0	4	_aDNA-Binding Proteins _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypoxia-Inducible Factor 1
650	0	4	_aHypoxia-Inducible Factor 1, alpha Subunit
650	0	4	_aMale
650	0	4	_aMutation
650	0	4	_aNuclear Proteins _xantagonists & inhibitors
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aProstatic Neoplasms _xgenetics
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aProto-Oncogene Proteins c-bcl-2
650	0	4	_aSubstrate Specificity
650	0	4	_aTranscription Factors
650	0	4	_aTranscription, Genetic
650	0	4	_aTranscriptional Activation _xphysiology
650	0	4	_aTumor Cells, Cultured
650	0	4	_aTumor Suppressor Protein p53 _xantagonists & inhibitors
650	0	4	_abcl-2-Associated X Protein
700	1		_aGiannakakou, P
700	1		_aRomanova, L Y
700	1		_aRyan, K M
700	1		_aVousden, K H
700	1		_aFojo, T
773	0		_tCarcinogenesis _gvol. 22 _gno. 6 _gp. 861-7
856	4	0	_uhttps://doi.org/10.1093/carcin/22.6.861 _zAvailable from publisher's website
999			_c11307578 _d11307578